BILL NUMBER: AB 6	CHAPTERED
	BILL TEXT

	CHAPTER   560
	FILED WITH SECRETARY OF STATE   SEPTEMBER 29, 1997
	APPROVED BY GOVERNOR   SEPTEMBER 28, 1997
	PASSED THE SENATE   SEPTEMBER 5, 1997
	PASSED THE ASSEMBLY   JUNE 3, 1997
	AMENDED IN ASSEMBLY   MARCH 3, 1997

INTRODUCED BY  Assembly Member Bowler

                        DECEMBER 2, 1996

   An act to amend Section 11055 of the Health and Safety Code,
relating to controlled substances, and declaring the urgency thereof,
to take effect immediately.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 6, Bowler.  Controlled substances:  gamma-hydroxybutyrate.
   Existing law categorizes controlled substances into 5 schedules
and places the greatest restrictions on those contained in Schedule
I.  Controlled substances contained in Schedule II may be lawfully
prescribed under limited circumstances.
   This bill would include in Schedule II the sedative and hypnotic
drug gamma-hydroxybutyrate.  This bill would impose a state-mandated
local program upon local governments by creating new crimes with
respect to gamma-hydroxybutyrate.
  The California Constitution requires the state to reimburse local
agencies and school districts for certain costs mandated by the
state.  Statutory provisions establish procedures for making that
reimbursement.
   This bill would provide that no reimbursement is required by this
act for a specified reason.
   This bill would declare that it is to take effect immediately as
an urgency statute.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:


  SECTION 1.  Section 11055 of the Health and Safety Code is amended
to read:
   11055.  (a) The controlled substances listed in this section are
included in Schedule II.
   (b) Any of the following substances, except those narcotic drugs
listed in other schedules, whether produced directly or indirectly by
extraction from substances of vegetable origin, or independently by
means of chemical synthesis, or by combination of extraction and
chemical synthesis:
   (1) Opium and opiate, and any salt, compound, derivative, or
preparation of opium or opiate, with the exception of naloxone
hydrochloride (N-allyl-14-hydroxy-nordihydromorphinone
hydrochloride), but including the following:
   (A) Raw opium.
   (B) Opium extracts.
   (C) Opium fluid extracts.
   (D) Powdered opium.
   (E) Granulated opium.
   (F) Tincture of opium.
   (G) Apomorphine.
   (H) Codeine.
   (I) Ethylmorphine.
   (J) Hydrocodone.
   (K) Hydromorphone.
   (L) Metopon.
   (M) Morphine.
   (N) Oxycodone.
   (O) Oxymorphone.
   (P) Thebaine.
   (2) Any salt, compound, isomer, or derivative, whether natural or
synthetic, of the substances referred to in paragraph (1), but not
including the isoquinoline alkaloids of opium.
   (3) Opium poppy and poppy straw.
   (4) Coca leaves and any salt, compound, derivative, or preparation
of coca leaves, but not including decocainized coca leaves or
extractions which do not contain cocaine or ecgonine.
   (5) Concentrate of poppy straw (the crude extract of poppy straw
in either liquid, solid, or powder form which contains the
phenanthrene alkaloids of the opium poppy).
   (6) Cocaine, except as specified in Section 11054.
   (7) Ecgonine, whether natural or synthetic, or any salt, isomer,
derivative, or preparation thereof.
   (c) Opiates.  Unless specifically excepted or unless in another
schedule, any of the following opiates, including its isomers,
esters, ethers, salts, and salts of isomers, esters, and ethers
whenever the existence of those isomers, esters, ethers, and salts is
possible within the specific chemical designation, dextrorphan and
levopropoxyphene excepted:
   (1) Alfentanyl.
   (2) Alphaprodine.
   (3) Anileridine.
   (4) Bezitramide.
   (5) Bulk dextropropoxyphene (nondosage forms).
   (6) Dihydrocodeine.
   (7) Diphenoxylate.
   (8) Fentanyl.
   (9) Isomethadone.
   (10) Levoalphacetylmethadol, also known as
levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM.  This
substance is authorized for the treatment of narcotic addicts under
federal law (see Part 291 (commencing with Section 291.501) and Part
1308 (commencing with Section 1308.01) of Title 21 of the Code of
Federal Regulations).
   (11) Levomethorphan.
   (12) Levorphanol.
   (13) Metazocine.
   (14) Methadone.
   (15) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl
butane.
   (16) Moramide-Intermediate, 2-methyl-3-morpholino-1,
1-diphenylpropane-carboxylic acid.
   (17) Pethidine (meperidine).
   (18) Pethidine-Intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine.
   (19) Pethidine-Intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate.
   (20) Pethidine-Intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid.
   (21) Phenazocine.
   (22) Piminodine.
   (23) Racemethorphan.
   (24) Racemorphan.
   (25) Sufentanyl.
   (d) Stimulants.  Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
stimulant effect on the central nervous system:
   (1) Amphetamine, its salts, optical isomers, and salts of its
optical isomers.
   (2) Methamphetamine, its salts, isomers, and salts of its isomers.

   (3) Dimethylamphetamine (N,N-dimethylamphetamine), its salts,
isomers, and salts of its isomers.
   (4) N-Ethylmethamphetamine (N-ethyl, N-methylamphetamine), its
salts, isomers, and salts of its isomers.
   (5) Phenmetrazine and its salts.
   (6) Methylphenidate.
   (e) Depressants.  Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system, including its salts,
isomers, and salts of isomers whenever the existence of those salts,
isomers, and salts of isomers is possible within the specific
chemical designation:
   (1) Amobarbital.
   (2) Pentobarbital.
   (3) Phencyclidines, including the following:
   (A) 1-(1-phenylcyclohexyl) piperidine (PCP).
   (B) 1-(1-phenylcyclohexyl) morpholine (PCM).
   (C) Any analog of phencyclidine which is added by the Attorney
General by regulation pursuant to this paragraph.
   The Attorney General, or his or her designee, may, by rule or
regulation, add additional analogs of phencyclidine to those
enumerated in this paragraph after notice, posting, and hearing
pursuant to Chapter 3.5 (commencing with Section 11340) of Part 1 of
Division 3 of Title 2 of the Government Code.  The Attorney General
shall, in the calendar year of the regular session of the Legislature
in which the rule or regulation is adopted, submit a draft of a
proposed bill to each house of the Legislature which would
incorporate the analogs into this code.  No rule or regulation shall
remain in effect beyond January 1 after the calendar year of the
regular session in which the draft of the proposed bill is submitted
to each house.  However, if the draft of the proposed bill is
submitted during a recess of the Legislature exceeding 45 calendar
days, the rule or regulation shall be effective until January 1 after
the next calendar year.
   (4) Secobarbital.
   (5) Glutethimide.
   (6) Gamma-hydroxybutyrate.
   (f) Immediate precursors.  Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances:

   (1) Immediate precursor to amphetamine and methamphetamine:
   (A) Phenylacetone.  Some trade or other names:  phenyl-2
propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.
   (2) Immediate precursors to phencyclidine (PCP):
   (A) 1-phenylcyclohexylamine.
   (B) 1-piperidinocyclohexane carbonitrile (PCC).
   (g) Hallucinogenic substances.  Any of the following
hallucinogenic substances:  dronabinol (synthetic) in sesame oil and
encapsulated in a soft gelatin capsule in a drug product approved by
the federal Food and Drug Administration.
  SEC. 2.  No reimbursement is required by this act pursuant to
Section 6 of Article XIIIB of the California Constitution because the
only costs that may be incurred by a local agency or school district
will be incurred because this act creates a new crime or infraction,
eliminates a crime or infraction, or changes the penalty for a crime
or infraction, within the meaning of Section 17556 of the Government
Code, or changes the definition of a crime within the meaning of
Section 6 of Article XIIIB of the California Constitution.
   Notwithstanding Section 17580 of the Government Code, unless
otherwise specified, the provisions of this act shall become
operative on the same date that the act takes effect pursuant to the
California Constitution.
  SEC. 3.  This act is an urgency statute necessary for the immediate
preservation of the public peace, health, or safety within the
meaning of Article IV of the Constitution and shall go into immediate
effect.  The facts constituting the necessity are:
   Since November of 1990, there have been increasing reports of the
dangers of the drug gamma-hydroxybutyrate.  There have been reports
that gamma-hydroxybutyrate has caused ailments ranging from nausea
and respiratory problems to seizures and comas, and according to
health care practitioners, the drug is very easy to overdose on and
has a potential for causing death. This act would seek to reduce
these dangerous occurrences by classifying the drug as a Schedule II
controlled substance so that the drug would only be lawfully
available for research and, under limited circumstances, upon
prescription by a licensed health care practitioner.  In order to
protect the health and well-being of the public as soon as possible,
it is necessary that this act go into immediate effect.